CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Login
View profile
Log out
Welcome back

Click below to sign in and see leads, RFIs or statistics

Sign in

Sign out
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54
Subscribe

Darbegen

Product Description

Indicated for Chronic Kidney Disease Anemia

Menagen Pharmaceuticals

Menagen Pharmaceuticals

Country/Region:

Oman
On CPHI since:

2024
Certificates:

1
Employees:

100 - 249

Company types

Biopharmaceutical company

Compare Add to favorites Added to favorites

Categories

Anatomical Therapeutic Chemical (ATC) Classification Products Blood and Blood Forming Organs
- Antianemic Preparations

Specifications

Details

Darbepoetin Alfa 20,30,40,60 mcg / 0.5 ml / PFS
Supplied from

Oman

Sales Markets

Middle East Region (e.g. UAE)

Menagen Pharmaceuticals

Menagen Pharmaceuticals

Country/Region:

Oman
On CPHI since:

2024
Certificates:

1
Employees:

100 - 249

Company types

Biopharmaceutical company

Compare Add to favorites Added to favorites

More Products from Menagen Pharmaceuticals (2)

Product Ezirosy

Treatment for Dyslipidemia

Compare
Product Nitisinone Menagen

Indicated for hereditary tyrosinemia type 1

Compare

Menagen Pharmaceuticals resources (1)

News taiba Make Strategic Investment in Immuneel Therapeutics to advance CAR T-cell Research and Make Therapies More Affordable

taiba has announced a strategic investment in Immuneel Therapeutics for $12 million.

23 Oct 2024